These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 28630011)
1. Interplay between hepatitis C virus and lipid metabolism during virus entry and assembly. Lavie M; Dubuisson J Biochimie; 2017 Oct; 141():62-69. PubMed ID: 28630011 [TBL] [Abstract][Full Text] [Related]
2. Role of lipid metabolism in hepatitis C virus assembly and entry. Popescu CI; Dubuisson J Biol Cell; 2009 Oct; 102(1):63-74. PubMed ID: 19857204 [TBL] [Abstract][Full Text] [Related]
3. Chronic hepatitis C virus infection and lipoprotein metabolism. Aizawa Y; Seki N; Nagano T; Abe H World J Gastroenterol; 2015 Sep; 21(36):10299-313. PubMed ID: 26420957 [TBL] [Abstract][Full Text] [Related]
4. HCV Interplay with Lipoproteins: Inside or Outside the Cells? Cosset FL; Mialon C; Boson B; Granier C; Denolly S Viruses; 2020 Apr; 12(4):. PubMed ID: 32290553 [TBL] [Abstract][Full Text] [Related]
5. Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies. Blaising J; Pécheur EI Biochimie; 2013 Jan; 95(1):96-102. PubMed ID: 22884392 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus relies on lipoproteins for its life cycle. Grassi G; Di Caprio G; Fimia GM; Ippolito G; Tripodi M; Alonzi T World J Gastroenterol; 2016 Feb; 22(6):1953-65. PubMed ID: 26877603 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus particles and lipoprotein metabolism. André P; Perlemuter G; Budkowska A; Bréchot C; Lotteau V Semin Liver Dis; 2005 Feb; 25(1):93-104. PubMed ID: 15732001 [TBL] [Abstract][Full Text] [Related]
8. Mouse hepatic cells support assembly of infectious hepatitis C virus particles. Long G; Hiet MS; Windisch MP; Lee JY; Lohmann V; Bartenschlager R Gastroenterology; 2011 Sep; 141(3):1057-66. PubMed ID: 21699799 [TBL] [Abstract][Full Text] [Related]
9. Lipoprotein component associated with hepatitis C virus is essential for virus infectivity. Shimizu Y; Hishiki T; Ujino S; Sugiyama K; Funami K; Shimotohno K Curr Opin Virol; 2011 Jul; 1(1):19-26. PubMed ID: 22440563 [TBL] [Abstract][Full Text] [Related]
10. Release of Infectious Hepatitis C Virus from Huh7 Cells Occurs via a trans-Golgi Network-to-Endosome Pathway Independent of Very-Low-Density Lipoprotein Secretion. Mankouri J; Walter C; Stewart H; Bentham M; Park WS; Heo WD; Fukuda M; Griffin S; Harris M J Virol; 2016 Aug; 90(16):7159-70. PubMed ID: 27226379 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease. Felmlee DJ; Hafirassou ML; Lefevre M; Baumert TF; Schuster C Viruses; 2013 May; 5(5):1292-324. PubMed ID: 23698400 [TBL] [Abstract][Full Text] [Related]
12. Permissiveness of human hepatocellular carcinoma cell lines for hepatitis C virus entry and replication. Coto-Llerena M; Koutsoudakis G; Boix L; López-Oliva JM; Caro-Pérez N; Fernández-Carrillo C; González P; Gastaminza P; Bruix J; Forns X; Pérez-Del-Pulgar S Virus Res; 2017 Aug; 240():35-46. PubMed ID: 28751105 [TBL] [Abstract][Full Text] [Related]
15. HCV Pit Stop at the Lipid Droplet: Refuel Lipids and Put on a Lipoprotein Coat before Exit. Vieyres G; Pietschmann T Cells; 2019 Mar; 8(3):. PubMed ID: 30871009 [TBL] [Abstract][Full Text] [Related]
16. The mechanism of HCV entry into host cells. Douam F; Lavillette D; Cosset FL Prog Mol Biol Transl Sci; 2015; 129():63-107. PubMed ID: 25595801 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus cell entry: role of lipoproteins and cellular receptors. Burlone ME; Budkowska A J Gen Virol; 2009 May; 90(Pt 5):1055-1070. PubMed ID: 19264629 [TBL] [Abstract][Full Text] [Related]
18. Neglected but Important Role of Apolipoprotein E Exchange in Hepatitis C Virus Infection. Yang Z; Wang X; Chi X; Zhao F; Guo J; Ma P; Zhong J; Niu J; Pan X; Long G J Virol; 2016 Nov; 90(21):9632-9643. PubMed ID: 27535051 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells. Shirasaki T; Honda M; Shimakami T; Horii R; Yamashita T; Sakai Y; Sakai A; Okada H; Watanabe R; Murakami S; Yi M; Lemon SM; Kaneko S J Virol; 2013 May; 87(9):5270-86. PubMed ID: 23449803 [TBL] [Abstract][Full Text] [Related]
20. Characterization of the inhibition of hepatitis C virus entry by in vitro-generated and patient-derived oxidized low-density lipoprotein. Westhaus S; Bankwitz D; Ernst S; Rohrmann K; Wappler I; Agné C; Luchtefeld M; Schieffer B; Sarrazin C; Manns MP; Pietschmann T; Ciesek S; von Hahn T Hepatology; 2013 May; 57(5):1716-24. PubMed ID: 23212706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]